Replies to post #115154 on Biotech Values

[BTH]

I agree.

ARIA would probably be valued over $1 billion if The Harv had ANY credibility whatsoever.

I'm sure people aren't really so much as questioning Ridaforolimus at this point, but questioning anything The Harv says about Merck's plans for the NDA, etc., and the actual hard-results of the drug. The Harv has essentially lied so many times to the Street over the years that I don't think anyone is ever going to forget about it.